Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Léa Baudre

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Medecine Sciences : M/S|May 24, 2022
[Decoding the function of bivalent chromatin]Léa Baudre, Céline Vallot, Justine Marsolier
Cancer Research|November 7, 2025
Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and PatientsLéa Baudre, Grégoire Jouault, Pacôme Prompsy, et al.
Cancer Research|November 6, 2025
Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and PatientsLéa Baudre, Gregoire Jouault, Pacôme Prompsy, et al.
Nature Genetics|April 12, 2022
H3K27me3 conditions chemotolerance in triple-negative breast cancerJustine Marsolier, Pacôme Prompsy, Adeline Durand, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Medecine Sciences : M/S|May 24, 2022
[Decoding the function of bivalent chromatin]Léa Baudre, Céline Vallot, Justine Marsolier
Cancer Research|November 7, 2025
Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and PatientsLéa Baudre, Grégoire Jouault, Pacôme Prompsy, et al.
Cancer Research|November 6, 2025
Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and PatientsLéa Baudre, Gregoire Jouault, Pacôme Prompsy, et al.
Nature Genetics|April 12, 2022
H3K27me3 conditions chemotolerance in triple-negative breast cancerJustine Marsolier, Pacôme Prompsy, Adeline Durand, et al.
Pageof 1